Viridian Therapeutics (VRDN)
(Delayed Data from NSDQ)
$12.70 USD
-0.33 (-2.53%)
Updated Apr 25, 2024 03:59 PM ET
After-Market: $12.95 +0.25 (1.97%) 5:12 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Earnings News For VRDN
-
Viridian Therapeutics Highlights Recent Progress and Reports Fourth Quarter and Full Year 2023 Financial Results
-
Viridian Therapeutics, Inc. (VRDN) Reports Q3 Loss, Lags Revenue Estimates
-
Viridian Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
-
Analysts Estimate Viridian Therapeutics, Inc. (VRDN) to Report a Decline in Earnings: What to Look Out for
-
Viridian Therapeutics, Inc. (VRDN) Reports Q2 Loss, Misses Revenue Estimates
-
Viridian Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
-
Viridian Therapeutics, Inc. (VRDN) Reports Q1 Loss, Misses Revenue Estimates
-
Viridian Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update
-
Viridian Therapeutics, Inc. (VRDN) Reports Q4 Loss, Lags Revenue Estimates
-
Viridian Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Updates
-
Viridian Therapeutics, Inc. (VRDN) Reports Q3 Loss, Tops Revenue Estimates
-
Viridian Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Updates
-
Viridian Therapeutics, Inc. (VRDN) Reports Q2 Loss, Misses Revenue Estimates
-
Viridian Therapeutics, Inc. (VRDN) Reports Q1 Loss, Lags Revenue Estimates
-
Viridian Therapeutics, Inc. (VRDN) Reports Q3 Loss, Misses Revenue Estimates
-
Will Viridian Therapeutics, Inc. (VRDN) Report Negative Earnings Next Week? What You Should Know
-
Will Viridian Therapeutics, Inc. (VRDN) Report Negative Q4 Earnings? What You Should Know